The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bio-identical Hormone Replacement Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Bioidentical hormone replacement therapy (BHRT) is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy.
The global Bio-identical Hormone Replacement Therapy market size is expected to reach US$ 9405.5 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Bio-identical Hormone Replacement Therapy in various end use industries. The expanding demands from the Men and Women, are propelling Bio-identical Hormone Replacement Therapy market. Creams, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injections segment is estimated at % CAGR for the next seven-year period.
The growing frequency of hormonal imbalance illnesses also aids the bioidentical hormone market's expansion. The health safety of the molecule bioidentical hormone, on the other hand, acts as a market restraint. The hormonal levels discovered in a patient with a hormonal imbalance are used to create customised bioidentical hormonal replacements. Additionally, the growing R&D activities by the key players for the discovery of novel therapeutics to treat hormonal imbalances and rising product approvals are expected to aid in the growth of the studied market over the forecast period. However, the high cost of hormone replacement therapy and the risk of developing cancers with HRTs are anticipated to hamper the market growth globally. Additionally, the rise and expansion of the healthcare sector, driven by both public and private actors, particularly in developing nations, will present profitable prospects for the personal health devices market. The market growth rate is also being supported by the governmental healthcare facilities' increased adoption of bioidentical hormone replacement therapy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bio-identical Hormone Replacement Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bio-identical Hormone Replacement Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bio-identical Hormone Replacement Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bio-identical Hormone Replacement Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bio-identical Hormone Replacement Therapy covered in this report include RevitaLife, SottoPelle, JumpstartMD, BioTE Medical and Aesthetic Everything, etc.
The global Bio-identical Hormone Replacement Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything
Global Bio-identical Hormone Replacement Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bio-identical Hormone Replacement Therapy market, Segment by Type:
Creams
Injections
Implanted Pellets
Patches
Gels
Global Bio-identical Hormone Replacement Therapy market, by Application
Men
Women
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bio-identical Hormone Replacement Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Bioidentical hormone replacement therapy (BHRT) is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy.
The global Bio-identical Hormone Replacement Therapy market size is expected to reach US$ 9405.5 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Bio-identical Hormone Replacement Therapy in various end use industries. The expanding demands from the Men and Women, are propelling Bio-identical Hormone Replacement Therapy market. Creams, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injections segment is estimated at % CAGR for the next seven-year period.
The growing frequency of hormonal imbalance illnesses also aids the bioidentical hormone market's expansion. The health safety of the molecule bioidentical hormone, on the other hand, acts as a market restraint. The hormonal levels discovered in a patient with a hormonal imbalance are used to create customised bioidentical hormonal replacements. Additionally, the growing R&D activities by the key players for the discovery of novel therapeutics to treat hormonal imbalances and rising product approvals are expected to aid in the growth of the studied market over the forecast period. However, the high cost of hormone replacement therapy and the risk of developing cancers with HRTs are anticipated to hamper the market growth globally. Additionally, the rise and expansion of the healthcare sector, driven by both public and private actors, particularly in developing nations, will present profitable prospects for the personal health devices market. The market growth rate is also being supported by the governmental healthcare facilities' increased adoption of bioidentical hormone replacement therapy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bio-identical Hormone Replacement Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bio-identical Hormone Replacement Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bio-identical Hormone Replacement Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bio-identical Hormone Replacement Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bio-identical Hormone Replacement Therapy covered in this report include RevitaLife, SottoPelle, JumpstartMD, BioTE Medical and Aesthetic Everything, etc.
The global Bio-identical Hormone Replacement Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything
Global Bio-identical Hormone Replacement Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bio-identical Hormone Replacement Therapy market, Segment by Type:
Creams
Injections
Implanted Pellets
Patches
Gels
Global Bio-identical Hormone Replacement Therapy market, by Application
Men
Women
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bio-identical Hormone Replacement Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bio-identical Hormone Replacement Therapy
1.1 Bio-identical Hormone Replacement Therapy Market Overview
1.1.1 Bio-identical Hormone Replacement Therapy Product Scope
1.1.2 Bio-identical Hormone Replacement Therapy Market Status and Outlook
1.2 Global Bio-identical Hormone Replacement Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bio-identical Hormone Replacement Therapy Market Size by Region (2018-2029)
1.4 Global Bio-identical Hormone Replacement Therapy Historic Market Size by Region (2018-2023)
1.5 Global Bio-identical Hormone Replacement Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bio-identical Hormone Replacement Therapy Market Size (2018-2029)
1.6.1 North America Bio-identical Hormone Replacement Therapy Market Size (2018-2029)
1.6.2 Europe Bio-identical Hormone Replacement Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Bio-identical Hormone Replacement Therapy Market Size (2018-2029)
1.6.4 Latin America Bio-identical Hormone Replacement Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Bio-identical Hormone Replacement Therapy Market Size (2018-2029)
2 Bio-identical Hormone Replacement Therapy Market by Type
2.1 Introduction
2.1.1 Creams
2.1.2 Injections
2.1.3 Implanted Pellets
2.1.4 Patches
2.1.5 Gels
2.2 Global Bio-identical Hormone Replacement Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bio-identical Hormone Replacement Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Bio-identical Hormone Replacement Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bio-identical Hormone Replacement Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bio-identical Hormone Replacement Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bio-identical Hormone Replacement Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bio-identical Hormone Replacement Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bio-identical Hormone Replacement Therapy Revenue Breakdown by Type (2018-2029)
3 Bio-identical Hormone Replacement Therapy Market Overview by Application
3.1 Introduction
3.1.1 Men
3.1.2 Women
3.2 Global Bio-identical Hormone Replacement Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bio-identical Hormone Replacement Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Bio-identical Hormone Replacement Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bio-identical Hormone Replacement Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bio-identical Hormone Replacement Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bio-identical Hormone Replacement Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bio-identical Hormone Replacement Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bio-identical Hormone Replacement Therapy Revenue Breakdown by Application (2018-2029)
4 Bio-identical Hormone Replacement Therapy Competition Analysis by Players
4.1 Global Bio-identical Hormone Replacement Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-identical Hormone Replacement Therapy as of 2022)
4.3 Date of Key Players Enter into Bio-identical Hormone Replacement Therapy Market
4.4 Global Top Players Bio-identical Hormone Replacement Therapy Headquarters and Area Served
4.5 Key Players Bio-identical Hormone Replacement Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Bio-identical Hormone Replacement Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 RevitaLife
5.1.1 RevitaLife Profile
5.1.2 RevitaLife Main Business
5.1.3 RevitaLife Bio-identical Hormone Replacement Therapy Products, Services and Solutions
5.1.4 RevitaLife Bio-identical Hormone Replacement Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 RevitaLife Recent Developments
5.2 SottoPelle
5.2.1 SottoPelle Profile
5.2.2 SottoPelle Main Business
5.2.3 SottoPelle Bio-identical Hormone Replacement Therapy Products, Services and Solutions
5.2.4 SottoPelle Bio-identical Hormone Replacement Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 SottoPelle Recent Developments
5.3 JumpstartMD
5.3.1 JumpstartMD Profile
5.3.2 JumpstartMD Main Business
5.3.3 JumpstartMD Bio-identical Hormone Replacement Therapy Products, Services and Solutions
5.3.4 JumpstartMD Bio-identical Hormone Replacement Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 BioTE Medical Recent Developments
5.4 BioTE Medical
5.4.1 BioTE Medical Profile
5.4.2 BioTE Medical Main Business
5.4.3 BioTE Medical Bio-identical Hormone Replacement Therapy Products, Services and Solutions
5.4.4 BioTE Medical Bio-identical Hormone Replacement Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 BioTE Medical Recent Developments
5.5 Aesthetic Everything
5.5.1 Aesthetic Everything Profile
5.5.2 Aesthetic Everything Main Business
5.5.3 Aesthetic Everything Bio-identical Hormone Replacement Therapy Products, Services and Solutions
5.5.4 Aesthetic Everything Bio-identical Hormone Replacement Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Aesthetic Everything Recent Developments
6 North America
6.1 North America Bio-identical Hormone Replacement Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bio-identical Hormone Replacement Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bio-identical Hormone Replacement Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bio-identical Hormone Replacement Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bio-identical Hormone Replacement Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bio-identical Hormone Replacement Therapy Market Dynamics
11.1 Bio-identical Hormone Replacement Therapy Industry Trends
11.2 Bio-identical Hormone Replacement Therapy Market Drivers
11.3 Bio-identical Hormone Replacement Therapy Market Challenges
11.4 Bio-identical Hormone Replacement Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
